Can tungsten exposure interfere with molybdenum-dependent enzymes?

Tungsten and molybdenum are chemically similar group 6 congeners. Because of this structural overlap, tungsten can readily interfere with essential molybdenum-dependent biological pathways.

Cellular transport and uptake competition

• Transport competition: Due to virtually identical ionic radii and oxyanion coordination geometries, tungstate ($\text{WO}_4^{2-}$) directly competes with molybdate for cellular transport systems.
• Depleted molybdenum pools: This shared uptake pathway means elevated tungsten exposure limits the intracellular availability of molybdenum, reducing the internal pool required for native enzyme synthesis.

Molecular and mechanistic substitution

• Cofactor displacement: Within the cell, tungsten competes for biosynthetic pathways, directly replacing molybdenum in the molybdopterin (MPT) active site.
• Complex formation: The organic MPT ligand accommodates tungsten using its dithiolene sulfur atoms, forming an inactive tungsten-molybdopterin (W-MPT or W-Moco) complex.

Catalytic inactivation

• Disrupted redox chemistry: Although the overall cofactor architecture remains intact, tungsten exhibits distinct redox potentials and stronger metal-ligand bond strengths than molybdenum.
• Enzymatic collapse: This substitution halts finely tuned catalytic cycles, rendering key eukaryotic molybdenum-dependent enzymes—such as sulfite oxidase and xanthine oxidase—catalytically inactive or severely impaired, which mimics the phenotype of molybdenum cofactor deficiency.

Bottom line

• Bottom line: Tungsten exposure directly impairs molybdenum-dependent enzymes. This occurs by competing for cellular uptake transport systems to deplete intracellular molybdenum, and by substituting for molybdenum within the molybdopterin cofactor, ultimately producing catalytically inactive enzymes.